The FDA has approved a label update for an inhaled insulin indicated for adults with type 1 or type 2 diabetes, according to ...
The agency issued a request for more information that will shape new regulation on ingredient transparency.
FDA drug alerts in endocrinology, including drug approvals, drug warnings, FDA medical device recalls, and FDA drug label ...
FDA requests information to explore whether current gluten labeling rules adequately protect consumers, with implications for ...
In what is shaping up to be a back-loaded month, the FDA is set to release a slew of regulatory decisions in February, ...
Sen. Rick Scott (R-Fla.) on Thursday unveiled legislation that would require prescription drug labels to include information ...
The U.S. Food and Drug Administration (FDA) is taking active steps to improve disclosure of gluten ingredients in foods.
The FDA has requested new human factors and pharmacology studies for Anaphylm sublingual film following deficiencies in original NDA packaging data.
The FDA proposes front-of-package "Nutrition Info boxes" to highlight saturated fat, sodium, and added sugars. The initiative aims to combat chronic diseases and promote healthier food choices. Large ...
Delve into the Amarin v. Hikma case in which the U.S. Supreme Court might settle the skinny label question once and for all.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results